Fatty Liver Disease in Obese Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

December 31, 2020

Conditions
ObesityNonalcoholic Fatty Liver DiseaseCardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

N-acetyl cysteine 600 mg once/day

NAC 600 mg once/day + Placebo once/day for 16 weeks

DIETARY_SUPPLEMENT

N-acetyl cysteine 600mg twice/day

N-acetyl cysteine 600 mg twice/day for 16 weeks

OTHER

Placebo twice/day

Placebo capsules twice/day for 16 weeks

Trial Locations (1)

32207

Nemours Children's Clinic/Alfred I duPont Hospital, Jacksonville

All Listed Sponsors
lead

Nemours Children's Clinic

OTHER

NCT02117700 - Fatty Liver Disease in Obese Children | Biotech Hunter | Biotech Hunter